Steven Brem

19.4k total citations · 2 hit papers
193 papers, 7.7k citations indexed

About

Steven Brem is a scholar working on Genetics, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Steven Brem has authored 193 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Genetics, 58 papers in Molecular Biology and 49 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Steven Brem's work include Glioma Diagnosis and Treatment (104 papers), Brain Metastases and Treatment (24 papers) and Angiogenesis and VEGF in Cancer (20 papers). Steven Brem is often cited by papers focused on Glioma Diagnosis and Treatment (104 papers), Brain Metastases and Treatment (24 papers) and Angiogenesis and VEGF in Cancer (20 papers). Steven Brem collaborates with scholars based in United States, Canada and United Kingdom. Steven Brem's co-authors include Henry Brem, Judah Folkman, Ramzi S. Cotran, David Zagzag, Ana Maria Crous Tsanaclis, Stephen Gately, Pietro M. Gullino, Steven Piantadosi, Melissa Walker and Nicholas A. Vick and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Steven Brem

184 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas

1995 1.1k citations Steven Brem et al. profile →
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme

2014 409 citations Steven Brem et al. profile →

Peers

Countries citing papers authored by Steven Brem

Since Specialization

Citations

This map shows the geographic impact of Steven Brem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Brem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Brem more than expected).

Fields of papers citing papers by Steven Brem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Brem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Brem. The network helps show where Steven Brem may publish in the future.

Co-authorship network of co-authors of Steven Brem

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Brem. A scholar is included among the top collaborators of Steven Brem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Brem. Steven Brem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Response Assessment in Long-Term Glioblastoma Survivors Using a Multiparametric MRI-Based Prediction Model 2025 ·Brain Sciences ·(unknown), (unknown), (unknown), (unknown), Arati Desai, Stephen Bagley, Steven Brem, Sanjeev Chawla, Suyash Mohan	0
2	The transformative potential of mRNA vaccines for glioblastoma and human cancer: technological advances and translation to clinical trials 2024 ·Frontiers in Oncology ·(unknown), Peter J. Madsen, Pedro R. Löwenstein, Maria G. Castro, Stephen Bagley, Yi Fan, Steven Brem	6
3	Quantitative Physiologic MRI Combined with Feature Engineering for Developing Machine Learning-Based Prediction Models to Distinguish Glioblastomas from Single Brain Metastases 2024 ·Diagnostics ·Seyyed Ali Hosseini, Stijn Servaes, (unknown), (unknown), (unknown), Pedro Rosa‐Neto, Steven Brem, Laurie A. Loevner, Suyash Mohan, Sanjeev Chawla	0
4	GLIOMA-06 THE GLIOMA CONNECTOME PROJECT – UPDATE 2023 ·Neuro-Oncology Advances ·Steven Brem	1
5	Brain network mapping and glioma pathophysiology 2023 ·Brain Communications ·(unknown), Steven Brem, John Suckling	14
6	Taming Glioblastoma in “Real Time”: Integrating Multimodal Advanced Neuroimaging/AI Tools Towards Creating a Robust and Therapy Agnostic Model for Response Assessment in Neuro-Oncology 2023 ·Clinical Cancer Research ·(unknown), Sanjeev Chawla, Steven Brem, Suyash Mohan	12
7	EPCO-26. INTRATUMORAL HETEROGENEITY OF GBM IDENTIFIED AND CHARACTERIZED BY A MULTISAMPLING APPROACH AND METHYLATION PROFILING 2023 ·Neuro-Oncology ·(unknown), Zied Abdullaev, Yuji Matsumoto, Steven Brem, Donald M. O’Rourke, Christos Davatzikos, Kenneth Aldape, MacLean P. Nasrallah	0
8	CHEX-seq detects single-cell genomic single-stranded DNA with catalytical potential 2023 ·Nature Communications ·Youtao Lu, (unknown), Jifen Li, Srinivasarao Allu, Jinhui Wang, Hyun‐Bum Kim, Kevin Bullaughey, Stephen Fisher, (unknown), (unknown), Stewart A. Anderson, Alexandra V. Ulyanova, Steven Brem, (unknown), John A. Wolf, M. Sean Grady, Sergei A. Vinogradov, Junhyong Kim, James Eberwine	3
9	Distinguishing Progression from Pseudoprogression in Glioblastoma Using¹⁸F-Fluciclovine PET 2022 ·Journal of Nuclear Medicine ·Ali Nabavizadeh, Stephen Bagley, Robert K. Doot, (unknown), (unknown), Satyam Ghodasara, Chao Zhao, Hannah Anderson, Erin K. Schubert, Erica L. Carpenter, Jacob E. Till, Fraser Henderson, Austin R. Pantel, H. Isaac Chen, John Y. K. Lee, Nduka Amankulor, Donald M. O’Rourke, Arati Desai, MacLean P. Nasrallah, Steven Brem	18
10	Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40 2021 ·Nature Communications ·Fan Yang, Zhenqiang He, Hao Duan, Duo Zhang, (unknown), Huijuan Yang, Jay F. Dorsey, Wei Zou, S. Ali Nabavizadeh, Stephen Bagley, Kalil G. Abdullah, Steven Brem, Lin Zhang, Xiaowei Xu, Katelyn T. Byrne, Robert H. Vonderheide, Yanqing Gong, Yi Fan	114
11	Wnt-mediated endothelial transformation into mesenchymal stem cell–like cells induces chemoresistance in glioblastoma 2020 ·Science Translational Medicine ·Menggui Huang, Duo Zhang, (unknown), (unknown), (unknown), Chunsheng Li, Lin Zhang, Eric C. Holland, Lutian Yao, Ling Qin, Zev A. Binder, Donald M. O’Rourke, Steven Brem, Constantinos Koumenis, Yanqing Gong, Yi Fan	106
12	An Integrated Stress Response Agent that Modulates DR5-Dependent TRAIL Synergy Reduces Patient-Derived Glioma Stem Cell Viability 2019 ·Molecular Cancer Research ·Saad Sheikh, Deeksha Saxena, Xiaobing Tian, Ahmad Amirshaghaghi, Andrew Tsourkas, Steven Brem, Jay F. Dorsey	7
13	Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study 2019 ·Clinical Cancer Research ·Stephen Bagley, Seyed Ali Nabavizadeh, (unknown), Jacob E. Till, Jeffrey B. Ware, (unknown), (unknown), (unknown), (unknown), (unknown), Theresa Christensen, Stephanie S. Yee, MacLean P. Nasrallah, Jennifer J.D. Morrissette, Zev A. Binder, Donald M. O’Rourke, Andrew J. Cucchiara, Steven Brem, Arati Desai, Erica L. Carpenter	81
14	Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma 2019 ·Academic Pathology ·MacLean P. Nasrallah, Zev A. Binder, Derek A. Oldridge, Jianhua Zhao, David Lieberman, Jacquelyn J. Roth, Christopher D. Watt, (unknown), Eva Klinman, Robert Daber, Arati Desai, Steven Brem, Donald M. O’Rourke, Jennifer J.D. Morrissette	16
15	Guidelines for the Initial Management of Metastatic Brain Tumors: Role of Surgery, Radiosurgery, and Radiation Therapy 2008 ·Journal of the National Comprehensive Cancer Network ·Matthew G. Ewend, David E. Morris, Lisa A. Carey, Alim Ladha, Steven Brem	51
16	Inhibition of Angiogenesis by Aβ Peptides 2004 ·Angiogenesis ·Daniel Paris, Kirk Townsend, Amita Quadros, James Humphrey, Jiazhi Sun, Steven Brem, (unknown), Anthony DelleDonne, Nikunj Patel, Demian Obregon, Robert M. Crescentini, Laila Abdullah, Domenico Coppola, Amyn M. Rojiani, Fiona Crawford, Saı̈d M. Sebti, Michael Mullan	122
17	Angiogenesis antagonists: current clinical trials 1998 ·Angiogenesis ·Steven Brem	18
18	Cells Transfected with the Basic Fibroblast Growth Factor Gene Fused to a Signal Sequence Are Invasive In Vitro and In Situ in the Brain 1995 ·Neurosurgery ·Stephen Gately, (unknown), Shingo Takano, Michael Klagsbrun, Steven Brem	17
19	Anticopper treatment inhibits pseudopodial protrusion and the invasive spread of 9L gliosarcoma cells in the rat brain 1990 ·Neurosurgery ·Steven Brem, Ana Maria Crous Tsanaclis, David Zagzag	66
20	Angiogenesis and Blood-Brain Barrier Breakdown Modulate CT Contrast Enhancement: An Experimental Study in a Rabbit Brain-Tumor Model 1989 ·American Journal of Neuroradiology ·David Zagzag, Marvin M. Goldenberg, Steven Brem	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact